Squaramide derivatives as CXCR2 antagonist

Details Squaramide derivatives as CXCR2 antagonist Squaramide derivatives as CXCR2 antagonist

2011-08-02

2011-08-02

Wilson, James O (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

C544S336000, C546S329000, C548S375100, C549S074000, C549S491000, C549S505000, C564S086000

Reexamination Certificate

active

07989497

ABSTRACT:
The present invention relates to compounds of formula (I)wherein X, R1, R2, R3, R4and R5are as defined herein, which are useful for treating diseases which respond to CXCR2 receptor mediators. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.

REFERENCES:
patent: 6166050 (2000-12-01), Lombardo et al.
patent: 7132445 (2006-11-01), Taveras et al.
patent: 2004/0106794 (2004-06-01), Taveras et al.
patent: 2004/0147559 (2004-07-01), Taveras et al.
patent: 2008/0200523 (2008-08-01), Murthi et al.
patent: 102005035742 (2007-02-01), None
patent: 1818325 (2010-02-01), None
patent: 02/057230 (2002-07-01), None
patent: 02/079122 (2002-10-01), None
patent: 02/083624 (2002-10-01), None
patent: 03/080053 (2003-10-01), None
patent: 2004/011418 (2004-02-01), None
patent: 2005/075447 (2005-08-01), None
patent: 2006/072354 (2006-07-01), None
patent: 2006/084661 (2006-08-01), None
patent: 2006/088920 (2006-08-01), None
patent: 2008/005570 (2008-01-01), None
patent: 2009/005801 (2009-01-01), None
patent: 2009/005802 (2009-01-01), None
patent: 2009/012375 (2009-01-01), None
patent: 2009/073683 (2009-06-01), None
patent: 2010/683802 (2010-06-01), None
patent: 2010/091543 (2010-08-01), None
Yun Feng Xie et al., “Structure-activity relationships of novel, highly potent, selective, and orally active CCR1 antogonists,” Bioorganic & Medicinal Chemistry Letters 15:3367-3372 (Apr. 5, 2007).

Affiliated with

Also associated with

Rating

Squaramide derivatives as CXCR2 antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Squaramide derivatives as CXCR2 antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Squaramide derivatives as CXCR2 antagonist will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2792451